Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification

S Chidambaranathan-Reghupaty, PB Fisher… - Advances in cancer …, 2021 - Elsevier
Hepatocellular carcinoma (HCC), the primary malignancy of hepatocytes, is a diagnosis with
bleak outcome. According to National Cancer Institute's SEER database, the average five …

[HTML][HTML] Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update

M Omata, AL Cheng, N Kokudo, M Kudo, JM Lee… - Hepatology …, 2017 - Springer
There is great geographical variation in the distribution of hepatocellular carcinoma (HCC),
with the majority of all cases worldwide found in the Asia–Pacific region, where HCC is one …

Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes

S Durinck, EW Stawiski, A Pavía-Jiménez… - Nature …, 2015 - nature.com
To further understand the molecular distinctions between kidney cancer subtypes, we
analyzed exome, transcriptome and copy number alteration data from 167 primary human …

Diagnosis and management of glycogen storage diseases type VI and IX: a clinical practice resource of the American College of Medical Genetics and Genomics …

PS Kishnani, J Goldstein, SL Austin, P Arn… - Genetics in …, 2019 - nature.com
Purpose Glycogen storage disease (GSD) types VI and IX are rare diseases of variable
clinical severity affecting primarily the liver. GSD VI is caused by deficient activity of hepatic …

Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I

J Calderaro, P Labrune, G Morcrette, S Rebouissou… - Journal of …, 2013 - Elsevier
BACKGROUND & AIMS: Hepatocellular adenomas (HCA) are benign liver tumors mainly
related to oral contraception and classified into 4 molecular subgroups: inflammatory (IHCA) …

Hepatocellular carcinoma: epidemiology, screening, and assessment of hepatic reserve

SZ Frager, JM Schwartz - Current Oncology, 2020 - mdpi.com
Hepatocellular carcinoma: epidemiology, screening, and assessment of hepatic reserve Page 1
S138 Current Oncology, Vol. 27, Supp. 3, November 2020 © 2020 Multimed Inc. REVIEW …

The natural history of glycogen storage disease types VI and IX: Long-term outcome from the largest metabolic center in Canada

A Roscher, J Patel, S Hewson, L Nagy… - Molecular genetics and …, 2014 - Elsevier
Objectives Glycogen storage disease (GSD) types VI and IX are caused by phosphorylase
system deficiencies. To evaluate the natural history and long-term treatment outcome of the …

[HTML][HTML] Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management

MK Singh, BK Das, S Choudhary, D Gupta… - Biomedicine & …, 2018 - Elsevier
Both diabetes mellitus (DM) and cancer are multifarious, dissimilar, and long-lasting, fatal
diseases with a remarkable influence on health worldwide. DM is not only related to …

[HTML][HTML] Glycogen storage diseases: An update

E Gümüş, H Özen - World Journal of Gastroenterology, 2023 - ncbi.nlm.nih.gov
Glycogen storage diseases (GSDs), also referred to as glycogenoses, are inherited
metabolic disorders of glycogen metabolism caused by deficiency of enzymes or …

Liver transplantation for pediatric metabolic disease

G Mazariegos, B Shneider, B Burton, IJ Fox… - Molecular genetics and …, 2014 - Elsevier
Liver transplantation (LTx) was initially developed as a therapy for liver diseases known to
be associated with a high risk of near-term mortality but is based upon a different set of …